A randomized, phase 2 trial of Docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic non-small-cell lung cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: D Ross Camidge John Nemunaitis Charles Rudin Daniel J Becker |
| Publication date | July 1, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |